Trials / Sponsors / Capricor Inc.
Capricor Inc.
Industry · 11 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy Muscular Dystrophies, Muscular Dystrophy, Duchenne, Muscular Disorders, Atrophic | Phase 3 | 2022-06-22 |
| Completed | Intravenous Infusion of CAP-1002 in Patients With COVID-19 Covid19 | Phase 2 | 2020-11-15 |
| Active Not Recruiting | Open-label Extension of the HOPE-2 Trial Duchenne Muscular Dystrophy | Phase 2 | 2020-08-05 |
| Completed | Halt cardiomyOPathy progrEssion in Duchenne (HOPE-OLE) Duchenne Muscular Dystrophy | Phase 2 | 2018-06-21 |
| Completed | A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy Muscular Dystrophies, Muscular Dystrophy, Duchenne, Muscular Disorders, Atrophic | Phase 2 | 2018-04-04 |
| Completed | HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne) Duchenne Muscular Dystrophy, Cardiomyopathy | Phase 2 | 2016-01-07 |
| Completed | Safety Study of Cenderitide in Chronic Stable Heart Failure With Moderate Renal Impairment Heart Failure, Renal Insufficiency | Phase 1 / Phase 2 | 2015-12-01 |
| Completed | Safety Study of Cenderitide in Stable Chronic Heart Failure Heart Failure | Phase 2 | 2015-01-01 |
| Unknown | Dilated cardiomYopathy iNtervention With Allogeneic MyocardIally-regenerative Cells (DYNAMIC) Dilated Cardiomyopathy (DCM), Ischemic Cardiomyopathy, Nonischemic Cardiomyopathy | Phase 1 | 2014-11-01 |
| Terminated | Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration Myocardial Infarction | Phase 1 / Phase 2 | 2012-11-13 |
| No Longer Available | CAP-1002 in Severe COVID-19 Disease COVID-19 | — | — |